Evommune, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2023 | — | — | $29.2M |
| FY2024 | $28.5M | $76.1M | $16.3M |
| FY2025 | $19.4M | $224.9M | $44.1M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2023 | — | — | $29.2M |
| FY2024 | $28.5M | $76.1M | $16.3M |
| FY2025 | $19.4M | $224.9M | $44.1M |